Drawing for ACT TO IMPROVE LIFE PROVEPHARM

USPTO serial 79417239

ACT TO IMPROVE LIFE PROVEPHARM

Reviewed by CopyMark Law Group

Reg. 7989149Status 700Registered
Filing date
Status date
Registration date
Oct 21, 2025
Examiner
HUSSAIN, TASNEEM
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACT TO IMPROVE LIFE PROVEPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kaitlyn M. Garvin

Kaitlyn M. Garvin Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical products in the nature of chemicals for use in industry and science; raw methylene blue for scientific or research use; chemical additives for use in manufacture of pharmaceuticals; proteins in raw material form for scientific and medical research; proteins used in manufacturing processes; chemical additives, namely, emulsifiers, vitamins, antioxidants, additives, emollients and proteins for manufacture of cosmetics; plant hormones being phytohormones; vitamins for manufacturing pharmaceutical products; stabilizing chemical agents, namely, enzyme stabilizers for vitaminsACTIVE—
005Clinical medical reagents; synthetic peptides for the treatment of blood poisoning for pharmaceutical use; medicines to treat conditions of the leg, hoof, ear, nose and throat for animals; vitamins for animals; medicated foams, oils, lotions, creams, balms, ointments, gels and milks for the treatment of skin for pharmaceutical, medical and veterinary use; phytotherapy preparations for medical use; vitamins and vitamin preparations; pharmaceutical diagnostic preparations for medical purposes for marking tissues by injection in surgery and in internal medicine; chemical products, namely, surgical dyes for medical use for marking tissues by injection in surgery and in internal medicine; injectable pharmaceutical solutions for use as radio-isotope markers for diagnostic use in surgical procedures; drug delivery agents in the form of vials in the nature of ampoules sold filled with injectable pharmaceutical solutions that facilitate delivery of pharmaceutical preparations; pre-filled syringes sold filled with antidotes for medical and clinical use and sold filled with injectable pharmaceutical, namely, surgical dyes for marking tissues by application in surgery and internal medicine; methylene blue to treat methemoglobinemia for medical use; methylene blue solutions, namely, surgical dyes for medical use; indigo carmine, namely, surgical dyes for medical use; indigo cumin solutions, namely, surgical dyes for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 20, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 19, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 21, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 1, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 1, 2026FIMPFINAL DISPOSITION PROCESSED—
Jan 21, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 8, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 23, 2025ALIEASSIGNED TO LIE—
Jun 14, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 14, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 15, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 14, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2025DOCKASSIGNED TO EXAMINER—
Feb 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 28, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 20, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance